Veracyte, Inc.
VCYT
$59.01
$2.253.96%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 139.07M | 140.64M | 131.87M | 130.16M | 114.47M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 139.07M | 140.64M | 131.87M | 130.16M | 114.47M |
| Cost of Revenue | 35.21M | 45.35M | 34.81M | 37.73M | 32.38M |
| Gross Profit | 103.87M | 95.28M | 97.07M | 92.44M | 82.09M |
| SG&A Expenses | 50.84M | 46.49M | 54.65M | 58.57M | 58.26M |
| Depreciation & Amortization | 3.29M | 3.33M | 3.33M | 3.29M | 3.21M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 116.43M | 116.02M | 108.76M | 115.85M | 111.57M |
| Operating Income | 22.65M | 24.61M | 23.11M | 14.31M | 2.90M |
| Income Before Tax | 29.97M | 40.63M | 18.89M | 1.25M | 7.43M |
| Income Tax Expenses | 1.27M | -515.00K | -248.00K | 2.23M | 381.00K |
| Earnings from Continuing Operations | 28.71M | 41.15M | 19.14M | -980.00K | 7.05M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 28.71M | 41.15M | 19.14M | -980.00K | 7.05M |
| EBIT | 22.65M | 24.61M | 23.11M | 14.31M | 2.90M |
| EBITDA | 28.08M | 29.91M | 28.38M | 19.80M | 8.27M |
| EPS Basic | 0.36 | 0.52 | 0.24 | -0.01 | 0.09 |
| Normalized Basic EPS | 0.24 | 0.22 | 0.20 | 0.17 | 0.06 |
| EPS Diluted | 0.35 | 0.50 | 0.24 | -0.01 | 0.09 |
| Normalized Diluted EPS | 0.23 | 0.22 | 0.20 | 0.17 | 0.06 |
| Average Basic Shares Outstanding | 79.54M | 79.18M | 78.73M | 78.39M | 78.03M |
| Average Diluted Shares Outstanding | 81.31M | 81.39M | 79.69M | 78.39M | 80.06M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |